MET and lung carcinoma: Our study investigated the largest dataset of MET fusions in lung cancer patients to date, and not only systematically investigated fusion partners, subtypes, and breakpoint preference, but also characterized concurrent mutation profiles, mutational signatures, and the tumor mutational burden of different MET fusion subtypes such as IGR-MET versus canonical fusions.